Takeda uses terahertz pulsed imaging for analysis of layer separation in tablets
Leading scientists at Takeda Pharmaceutical Company have conducted groundbreaking quality control research of layer separation of pharmaceutical tablets using Terahertz Pulsed Imaging (TPI™). Data collection and findings are based on their use of TeraView’s TPI imaga 2000 system and are published in the International Journal of Pharmaceutics.
University of Arkansas chooses TeraView for medical imaging and nanomaterial research
TeraView has supplied a state-of-the-art terahertz imaging system to the University of Arkansas. The TPS Spectra 3000 will expand the use of terahertz radiation in a variety of research fields like breast cancer imaging and the fabrication of nanoscale materials.
Graham Hibberd joins TeraView as head of business development for analytical business
TeraView is pleased to announce the addition of Graham Hibberd to its team as Head of Analytical Business Development.
University of California, San Diego uses TeraView's instrument for near-field microscopy
TeraView, the pioneer and leader in terahertz solutions and technology, has successfully delivered a TPS Spectra 3000 system to the Infrared Laboratory for Novel Infrared and Magnetic Materials at the University of California, San Diego, founded and let by Professor Dimitri Basov.
Key laboratories in France select TeraView
TeraView has been chosen to supply systems to the Georgia Tech-CNRS laboratory in Metz and the LOMA laboratory at the University of Bordeaux.
TeraView Ltd. appoints Lynsey Wilson as new Chief Financial Officer
TeraView, the pioneer and leader in terahertz solutions and technology, are pleased to announce that Lynsey Wilson has joined the Company as Chief Financial Officer.
TeraView brings new techniques to the study of industrial coatings
TeraView, which is commercialising active terahertz technology, now brings techniques developed for medicine and pharmaceutical products to non-destructive testing for coatings, studies of adhesion.
TeraView receives MHRA approval to conduct in-vivo cancer imaging trials
TeraView Ltd., the pioneer and leader in terahertz solutions and technology, is pleased to announce that it has received approval by the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct in-vivo clinical trials for (bio)medical research using Terahertz Pulsed Imaging (TPI™).
Innovation cash boost for manufacturing
Two Cambridge UK technology innovators – TeraView and TWI (The Welding Institute) – have been chosen to lead initiatives in a new Government investment designed to stimulate innovation in manufacturing.
TeraView appoints Sector Technologies as exclusive European agent
TeraView Ltd., the pioneer and leader in terahertz solutions and technology is pleased to announce that it has appointed Sector Technologies as its agent in Europe for sales of its products into the Semiconductor Industry.